Dynamic changes in IGF-1 levels during cabergoline therapy in prolactinoma
{{output}}
Background: Cabergoline, a dopamine agonist widely used in prolactinoma treatment, also suppresses growth hormone (GH) and insulin-like growth factor-1 (IGF-1), though its long-term effects on IGF-1 levels in prolactinoma remain ... ...
